The glycoprotein (gp55) encoded by Friend spleen focusforming virus (SFFV) binds to erythropoietin receptors (EpoR) to stimulate erythroblastosis (2, 7, 13, 17, 36, 37) . Although gp55 occurs predominantly as a monomer in the rough endoplasmic reticulum, a small percentage (ca. 5%) is processed as a disulfide-bonded dimer to plasma membranes (9) . Evidence that EpoR activation involves only the cell surface dimer component of gp55 (7) is consistent with other information that dimerization may be involved in activating the EpoR superfamily of receptors (5, 6, 8, 33) . Chemical crosslinking studies have indicated that erythropoietin and gp55 bind to nearby nonoverlapping sites on EpoR (2, 7) .
The sites on gp55 necessary for EpoR binding and activation remain unknown. gp55 is a recombinant env glycoprotein with an amino-terminal dualtropic domain followed by an ecotropic domain and a carboxyl-terminal hydrophobic membrane anchor (10, 18, 22) . Different studies have suggested that mutations in any of these regions can eliminate pathogenesis (1, 3, 13, 14, 16, 19, 29, 31, 32, 37) . A more definitive approach toward resolving this matter is to identify substantially altered forms of gp55 that retain the ability to activate EpoR. For example, the BB6 mutant of SFFV activates EpoR but contains a partial deletion in its ecotropic region (13, 20) . Unlike wild-type SFFV, BB6 causes pathogenesis in Fv-2r homozygous mice (13, 20) . An EpoR-gp55 fusion protein that lacks dualtropic sequences can also activate intact EpoR, perhaps by a mechanism that involves both regions of the fusion protein (26) .
Recently we isolated an SFFV mutant (PvuA) that activates EpoR in a cell culture model system and encodes a gp4l glycoprotein that forms a cell surface complex with EpoR (7). Since this is the smallest env glycoprotein known to activate EpoR, we further analyzed its biological and structural properties. In vivo, PvuA causes multiple spleen foci within 10 days ( Table 1 ), suggesting that the injected virus is pathogenic (10) . Some of the infected mice then developed long latency splenomegaly and polycythemia whereas others recovered or developed a chronic indolent disease (Table 1) . By 80 days, most of the mice appeared normal, with the exception of one mouse that had splenomegaly and severe anemia. Anemia is generally associated with progression to the leukemic transplantable stage of Friend disease, regardless of the SFFV strain (27) . This occurs because the immortalized transplantable cells are blocked in their differentiation in vivo and because they overgrow the normal marrow (27) . Cell lysates prepared from this enlarged spleen were immunoprecipitated with an antiFriend leukemia virus gp7O antiserum (9, 23, 24) and electrophoresed in polyacrylamide gels under reducing conditions in the presence of 1% sodium dodecyl sulfate. The proteins were then transferred to nitrocellulose membranes, incubated with the same antibody, and detected with "2I-protein A as described previously (9, 16) . The spleen of the diseased mouse was found to contain a gp4l that coelectrophoresed with the original PvuA glycoprotein (Fig. 1, compare lanes 3 and 6) . Two cell lines were also derived by intraperitoneal transplantation of cells from this spleen into sublethally irradiated secondary recipients and growth of omental tumors (28, 34 (7, 13) . By 16 days postfusion, the culture medium contained a high titer of PvuA virus as indicated by infection of NIH/3T3 mouse fibroblasts. The helper-free PvuA virus was mixed with a nonpathogenic biological clone of a replication competent Friend murine leukemia virus (clone B4) prior to tail vein injection into mice as described elsewhere (9, 13, 15, 16, 18, 27) . Control mice were injected with the helper virus only.
d At least 30 foci were observed on spleens after being fixed in Bouin's solution as described previously (13) .
'ND, not done f Spleen lysates from this animal were examined by Western blot (Fig. 1) . The spleen cells from this animal were injected intraperitoneally into sublethally irradiated mice to develop the cell lines described in the text, and passaged virus was prepared from this spleen. (25) . The resulting sequence is compared with that of the wild-type SFFV env in Fig. 2 sequence because of a 204-base deletion in the ecotropicspecific region that eliminates the amino acids between positions 307 and 376 (35) . The Pvuz\ sequence also has a two-amino-acid insertion at amino acid position 194 because of a previously described linker insertion, which has no effect on biological activity (16) , and a T-to-A substitution at amino acid position 134 (Fig. 2) .
Comparison of SFFV-related env glycoproteins that activate EpoR allows several important conclusions. The previously analyzed BB6 SFFV mutant has an overlapping smaller deletion between amino acids 331 and 385 (20) . Together, these deletions eliminate almost the entire ecotropic-specific domain that precedes the hydrophobic membrane anchor at the carboxyl terminus (Fig. 2) . Although there has been controversy regarding initial evidence that env glycoproteins of replicationcompetent dualtropic murine retroviruses (MCFs) can activate EpoR (12) (13) (14) 30) , we recently isolated a novel MCF that reproducibly has this activity (9a). Moreover, MCF gp7O forms a complex with EpoR (13, 14) . However, MCFs do not cause rapid extensive erythroblastosis in vivo. Thus, the dualtropic domain common to gp55 and MCF gp7O must be important for activating EpoR, whereas the ecotropic sequences (195 amino acids) present in MCF env glycoproteins but absent from gp55 must have a negative modulatory role in the disease process. The sequence deletions described here and for the BB6 env mutant remove additional ecotropic sequences and attenuate but do not eliminate pathogenesis in NIH/Swiss mice. Our hypothesis that ecotropic sequences can serve as a negative control region in certain hosts is compatible with the observation that the BB6 env deletion overcomes resistance of Fv-2rr homozygous mice to Friend SFFV-induced erythroblastosis (20) . Similarly, the PvuA virus has a broader host range than wild-type SFFV. It causes pathogenesis in Fv-2' homozygous mice. Furthermore, human EpoR is resistant to wild-type SFFV but is efficiently activated by Pvuz (9b (4, 10) .
Nucleotide sequence accession number. The GenBank accession number for the PvuA env sequence is L27432.
